Case Study
IQVIA eCOA Delivers on a Tight Timeline for a Sickle Cell Disease Study
Rapid eCOA deployment and team expertise come together to expedite first patient in for a large, multipart study
Aug 22, 2024

In this case study, discover how a large pharmaceutical company was able to work with IQVIA eCOA to exceed study start up timelines for an extremely complex Sickle Cell Disease trial.

Related solutions

Contact Us